Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 12, 2015 06:00 ET | Source: Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals CEO Named "Entrepreneur of the Year" by Ernst & Young

PLYMOUTH MEETING, Pa., June 12, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that Inovio's Chief Executive Officer, Dr. J. Joseph Kim, has been selected as the...
May 27, 2015 01:00 ET | Source: Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals Partners with GeneOne Life Science for MERS Immunotherapy Clinical Development

PLYMOUTH MEETING, Pa., May 27, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced it will advance its DNA vaccine for MERS (Middle East Respiratory Syndrome) into a phase I...
May 26, 2015 08:00 ET | Source: Inovio Pharmaceuticals, Inc.

Inovio to Present at Jefferies Healthcare Conference

PLYMOUTH MEETING, Pa., May 26, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that Dr. J. Joseph Kim, President and CEO, will give a corporate presentation at the...
May 12, 2015 05:00 ET | Source: Inovio Pharmaceuticals, Inc.

Inovio Initiates Clinical Trial With DNA Immunotherapies to Prevent and Treat Ebola

PLYMOUTH MEETING, Pa., May 12, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that the company has initiated a phase I trial to evaluate safety, tolerability and...
May 11, 2015 07:00 ET | Source: Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals Reports 2015 First Quarter Financial Results

PLYMOUTH MEETING, Pa., May 11, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) today reported financial results for the quarter ended March 31, 2015. Total revenue was $5.2...
May 05, 2015 12:19 ET | Source: Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals Closes $87.4 Million Underwritten Financing

PLYMOUTH MEETING, Pa., May 5, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) ("Inovio" or the "Company"), today closed its previously announced underwritten public offering of...
May 01, 2015 08:00 ET | Source: Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals to Report First Quarter 2015 Financial Results May 11, 2015

PLYMOUTH MEETING, Pa., May 1, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that it will host a conference call and live webcast to report its 2015 first quarter...
April 30, 2015 09:00 ET | Source: Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock

PLYMOUTH MEETING, Pa., April 30, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) ("Inovio" or the "Company"), today announced the pricing of an underwritten public offering of...
April 29, 2015 16:01 ET | Source: Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals Announces Public Offering of Common Stock

PLYMOUTH MEETING, Pa., April 29, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) ("Inovio" or the "Company"), today announced that it intends to offer and sell shares of its common...
April 21, 2015 03:00 ET | Source: Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals and Roche Initiate Clinical Trial for Inovio's DNA Immunotherapy to Treat Chronic Hepatitis B Infection

PLYMOUTH MEETING, Pa., April 21, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that it has initiated a phase I trial to evaluate Inovio's DNA immunotherapy in...